Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed

Erin E. Salo‐Mullen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9602-8264; OpenAlex author ID A5017978796. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
29
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: 1 paper

Papers 8

  1. An Emerging Paradigm for Germline Testing in Pancreatic Ductal Adenocarcinoma and Immediate Implications for Clinical Practice: A Review. Co-author DOI 10.1001/jamaoncol.2019.5963↗
  2. Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2. Co-author DOI 10.1158/1940-6207.capr-18-0272↗
  3. Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adeno… Co-author DOI 10.1002/cncr.31218↗
  4. Evaluating Mismatch Repair Deficiency in Pancreatic Adenocarcinoma: Challenges and Recommendations. Co-author DOI 10.1158/1078-0432.ccr-17-3099↗
  5. Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches. Co-author DOI 10.1586/17474124.2016.1153424↗
  6. Identification of germline genetic mutations in patients with pancreatic cancer. Co-author DOI 10.1002/cncr.29664↗
  7. Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer. First author DOI 10.1002/cncr.26191↗
  8. An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions. Co-author DOI 10.1634/theoncologist.2011-0185↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zsofia Kinga Stadler · 8 shared papers, 2011–2020 · strength 0.52
  2. Eileen Mary O'Reilly · 6 shared papers, 2011–2020 · strength 0.40
  3. David Paul Kelsen · 6 shared papers, 2011–2018 · strength 0.28
  4. Maeve Aine Lowery · 5 shared papers, 2011–2018 · strength 0.26
  5. Kenneth H. Yu · 4 shared papers, 2011–2018 · strength 0.19
  6. Robert C. Kurtz · 4 shared papers, 2011–2019 · strength 0.18
  7. Michael Rainone · 1 shared paper, 2020 · strength 0.15
  8. Isha Singh · 1 shared paper, 2020 · strength 0.15
  9. İbrahim Halil Şahin · 2 shared papers, 2016–2018 · strength 0.13
  10. Christine A. Iacobuzio–Donahue · 2 shared papers, 2016–2018 · strength 0.13
  11. Amethyst Saldia · 2 shared papers, 2015–2019 · strength 0.13
  12. Marinela Capanu · 2 shared papers, 2018 · strength 0.13
  13. Leonard B. Saltz · 2 shared papers, 2015–2018 · strength 0.10
  14. Andrew S. Epstein · 2 shared papers, 2015–2018 · strength 0.10
  15. Mark E. Robson · 3 shared papers, 2011–2015 · strength 0.09
  16. Sara H. Olson · 1 shared paper, 2019 · strength 0.09
  17. Peter J. Allen · 1 shared paper, 2019 · strength 0.09
  18. Anna M. Varghese · 1 shared paper, 2018 · strength 0.07
  19. Zishuo I. Hu · 1 shared paper, 2018 · strength 0.07
  20. Luis Alberto Diaz · 1 shared paper, 2018 · strength 0.07
  21. Talia Golan · 1 shared paper, 2018 · strength 0.06
  22. Neesha C. Dhani · 1 shared paper, 2018 · strength 0.06
  23. Hedy Lee Kindler · 1 shared paper, 2018 · strength 0.06
  24. Amiel Segal · 1 shared paper, 2018 · strength 0.06
  25. Malcolm J. Moore · 1 shared paper, 2018 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.